EFTR eFFECTOR Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: EFTR

Price (delayed)

$2.2

Market cap

$8.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$16.37

Enterprise value

$13.78M

effector therapeutics is a biotechnology company located in 11180 roselle street, san diego, ca, united states.

Highlights
The EPS has contracted by 19% YoY but it has grown by 14% from the previous quarter
The revenue has plunged by 100% from the previous quarter and by 100% YoY
The gross profit has plunged by 100% from the previous quarter and by 100% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://effector.com/
Peers: OMER OMGA

Key stats

What are the main financial stats of EFTR
Market
Shares outstanding
3.69M
Market cap
$8.11M
Enterprise value
$13.78M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$32.89M
EBITDA
-$32.78M
Free cash flow
-$29.65M
Per share
EPS
-$16.37
Free cash flow per share
-$13.56
Book value per share
-$2.24
Revenue per share
$0
TBVPS
$9.39
Balance sheet
Total assets
$20.54M
Total liabilities
$26.34M
Debt
$20.55M
Equity
-$5.8M
Working capital
-$5.96M
Liquidity
Debt to equity
-3.55
Current ratio
0.77
Quick ratio
0.71
Net debt/EBITDA
-0.17
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-160%
Return on equity
N/A
Return on invested capital
-501.8%
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EFTR stock price

How has the eFFECTOR Therapeutics stock price performed over time
Intraday
1.85%
1 week
16.4%
1 month
-86.64%
1 year
-82.04%
YTD
-81.17%
QTD
-84.71%

Financial performance

How have eFFECTOR Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$33.84M
Net income
-$35.81M
Gross margin
N/A
Net margin
N/A
The revenue has plunged by 100% from the previous quarter and by 100% YoY
The gross profit has plunged by 100% from the previous quarter and by 100% YoY
eFFECTOR Therapeutics's net income has shrunk by 58% YoY
eFFECTOR Therapeutics's operating income has decreased by 4.4% YoY

Growth

What is eFFECTOR Therapeutics's growth rate over time

Valuation

What is eFFECTOR Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 19% YoY but it has grown by 14% from the previous quarter
The equity has declined by 46% since the previous quarter
The revenue has plunged by 100% from the previous quarter and by 100% YoY

Efficiency

How efficient is eFFECTOR Therapeutics business performance
eFFECTOR Therapeutics's ROA has plunged by 180% YoY and by 9% from the previous quarter
The ROIC has dropped by 57% since the previous quarter

Dividends

What is EFTR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EFTR.

Financial health

How did eFFECTOR Therapeutics financials performed over time
eFFECTOR Therapeutics's total assets is 22% less than its total liabilities
The quick ratio has declined by 32% year-on-year and by 5% since the previous quarter
eFFECTOR Therapeutics's current ratio has decreased by 31% YoY and by 6% from the previous quarter
eFFECTOR Therapeutics's debt to equity has shrunk by 168% YoY but it has increased by 31% QoQ
The equity has declined by 46% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.